351 related articles for article (PubMed ID: 20375806)
1. Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study.
Lee SW; Nam JH; Kim DY; Kim JH; Kim KR; Kim YM; Kim YT
Int J Gynecol Cancer; 2010 Apr; 20(3):411-6. PubMed ID: 20375806
[TBL] [Abstract][Full Text] [Related]
2. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH
Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455
[TBL] [Abstract][Full Text] [Related]
3. Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases.
Lan-Fang L; Hai-Yan S; Zuo-Ming Y; Jian-Qing Z; Ya-Qing C
Eur J Gynaecol Oncol; 2012; 33(1):68-73. PubMed ID: 22439409
[TBL] [Abstract][Full Text] [Related]
4. Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review.
Nagao S; Miwa M; Maeda N; Kogiku A; Yamamoto K; Morimoto A; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Sakuma T; Fujiwara K
Int J Gynecol Cancer; 2015 Sep; 25(7):1300-5. PubMed ID: 26166556
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
6. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.
Viswanathan AN; Deavers MT; Jhingran A; Ramirez PT; Levenback C; Eifel PJ
Gynecol Oncol; 2004 Apr; 93(1):27-33. PubMed ID: 15047210
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological Aspects of Small Cell Neuroendocrine Carcinoma of the Uterine Cervix: a Multicenter Retrospective Study and Meta-Analysis.
Xu F; Ma J; Yi H; Hu H; Fan L; Wu P; Chen X; Wu X; Yu L; Xing H; Wang W
Cell Physiol Biochem; 2018; 50(3):1113-1122. PubMed ID: 30355937
[TBL] [Abstract][Full Text] [Related]
9. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix.
Yuan L; Jiang H; Lu Y; Guo SW; Liu X
Int J Gynecol Cancer; 2015 Sep; 25(7):1315-21. PubMed ID: 26186071
[TBL] [Abstract][Full Text] [Related]
11. Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
Pei X; Xiang L; Ye S; He T; Cheng Y; Yang W; Wu X; Yang H
Gynecol Oncol; 2017 Dec; 147(3):589-596. PubMed ID: 28954697
[TBL] [Abstract][Full Text] [Related]
12. Population-Based Survival Analysis of Stage IVB Small-Cell Neuroendocrine Carcinoma in Comparison to Major Histological Subtypes of Cervical Cancer.
Mabuchi S; Komura N; Sasano T; Sakata M; Matsuzaki S; Hisa T; Kamiura S; Morishima T; Miyashiro I
Curr Oncol; 2023 Oct; 30(11):9428-9436. PubMed ID: 37999102
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and outcome of patients with small cell neuroendocrine carcinoma of the uterine cervix: case series and literature review.
Wang Y; Mei K; Xiang MF; Li JM; Xie RM
Eur J Gynaecol Oncol; 2013; 34(4):307-10. PubMed ID: 24020135
[TBL] [Abstract][Full Text] [Related]
14. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
[TBL] [Abstract][Full Text] [Related]
15. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic analysis of small cell neuroendocrine carcinoma of the cervix].
Qin JC; Li L; Yang ZJ; Yao DS; Li F; Zhang JQ
Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):360-3. PubMed ID: 21733373
[TBL] [Abstract][Full Text] [Related]
17. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
18. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and treatment comparison in small cell neuroendocrine carcinoma of the uterine cervix based on population analyses.
Lin LM; Lin Q; Liu J; Chu KX; Huang YX; Zhang ZK; Li T; Dai YQ; Li JL
Cancer Med; 2020 Sep; 9(18):6524-6532. PubMed ID: 32705800
[TBL] [Abstract][Full Text] [Related]
20. Small cell neuroendocrine carcinoma of the cervix with involvement of multiple pelvic nodes--A successfully treated case by multimodal approach.
Lim FK; Chong SM; Sethi V
Gynecol Oncol; 1999 Feb; 72(2):246-9. PubMed ID: 10021309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]